99985-63-4

Usage

Uses

Used in Sports Supplements and Bodybuilding Products:
N-Benzyl-2-methyl-beta-alanine ethyl ester is used as a performance-enhancing ingredient for its capacity to boost muscle carnosine levels. This increase is believed to improve athletic performance and endurance by reducing the build-up of lactic acid in muscles during high-intensity physical activity, thereby delaying the onset of muscle fatigue.
Used in Research and Development:
In the scientific community, N-Benzyl-2-methyl-beta-alanine ethyl ester is utilized in research studies to explore its potential antioxidant and neuroprotective properties. These investigations aim to understand the compound's full range of effects on human health and its possible applications in therapeutic areas.
Used in Pharmaceutical Formulations:
Although its safety and effectiveness are still under scrutiny, N-Benzyl-2-methyl-beta-alanine ethyl ester may be incorporated into pharmaceutical formulations for conditions where enhanced endurance or muscle performance could be beneficial. This could include applications in managing fatigue-related symptoms in certain medical conditions, pending further research and regulatory approval.

Upstream product

• 97-63-2 methyl methacrylate 
• 100-46-9 benzylamine 
• 80-62-6 methacrylic acid methyl ester 

Downstream Products

• 61283-01-0 2-Methyl-3-benzylamino-propionsaeure-hydrazid 
• 68710-76-9 N-(2-Aethoxycarbonylpropyl)-N-(aethoxycarbonylaethyl)-benzylamin 
• 104039-77-2 3-{1-Benzyl-3-[2-(3,4-dimethoxy-phenyl)-ethyl]-ureido}-2-methyl-propionic acid ethyl ester 
• 104020-89-5 3-{1-Benzyl-3-[2-(3,4-dimethoxy-phenyl)-2-phenyl-ethyl]-ureido}-2-methyl-propionic acid ethyl ester 
• 482358-56-5 ethyl 4-aza-4-(tert-butoxycarbonyl)-5-phenyl-2-methylpentanoate 
• 203928-17-0 N-benzyl-N-(2-methylbut-3-enyl)amine 
• 203927-88-2 [Benzyl-(2-methyl-but-3-enyl)-amino]-acetic acid methyl ester 
• 107610-71-9 N-ethoxycarbonylmethyl-N-(2-ethoxycarbonylpropyl)benzylamine 
• 104020-93-1 1-Benzyl-3-[2,2-bis-(3,4-dimethoxy-phenyl)-ethyl]-4-hydroxy-5-methyl-tetrahydro-pyrimidin-2-one 
• 104020-92-0 1-Benzyl-3-[2-(3,4-dimethoxy-phenyl)-2-phenyl-ethyl]-4-hydroxy-5-methyl-tetrahydro-pyrimidin-2-one 
• 104020-86-2 1-Benzyl-3-[2-(3,4-dimethoxy-phenyl)-ethyl]-4-hydroxy-5-methyl-tetrahydro-pyrimidin-2-one 

Relevant academic research and scientific papers

Total synthesis of (±)-symbioimine

The synthesis of (±)-symbioimine (1) has been completed in only 12 linear steps in 8% overall yield. The key step is the treatment of 13b with BF3·Et2O to generate N-carboalkoxydihydropyridinium cation 14b, which undergoes a novel stereospecific intramole

Synthesis of 2,4-, 3,4- and 2,3,4-substituted pyrrolidines by cyclization of neutral C-centered α-aminoalkyl radicals

The effect of substitution at C-3 or C-4 of the 2-azahex-5-enyl chain has been studied in the SmI2-promoted cyclizations of neutral α-aminoalkyl radicals generated from N-(α-benzotriazolyl)alkenylamines. 2,4-, 3,4- and 2,3,4-substituted pyrroli

Quinoline, naphthyridine and pyridobenzoxazine derivatives

Novel antibacterial compounds are disclosed having the formula STR1 as well as pharmaceutically acceptable salts, esters, amide and prodrugs thereof, wherein R1 is selected from the group consisting of (a) lower alkyl, (b) halo(lower alkyl), (c

Quinoline-3-carboxylic acid derivatives

Compounds of formula (I): STR1 (in which R1 is alkoxy, R is alkyl, haloalkyl, alkylamino, cycloalkyl or optionally substituted phenyl, X is chlorine or fluorine and Y is selected from certain specific heterocycles) have excellent antibacterial activity. They may be prepared by introducing the group represented by Y into the corresponding compound in which Y is replaced by a halogen atom.

Pyridonecarboxylic acid derivatives and antibacterial pharmaceutical compositions thereof

Pyridonecarboxylic acid derivatives of the following formula, STR1 wherein R is hydrogen atom or lower alkyl group, R1 is lower alkyl group, cycloalkyl group or haloalkyl group, Y is hydrogen atom or halogen atom, or Y and R1 are STR